NEURO61

Session information

[held on paper]English Poster Session

[Pe-08] English Poster Session 08
Muscle disease/Metabolic disease

Tomoya Kubota1, Kei Fujiwara2, Risa Yamamoto1, Itsuki Mori1, Tasuku Ohso1, Yuko Suzuki3, Masayoshi Kamon4, Toshiyuki Araki4, Hidetoshi Sakurai2, Masanori Takahashi1 (1.Lab of Clinical neurophysiology, Osaka University Graduate School of Medicine, Japan, 2.Center for iPS Cell Research and Application (CiRA), Kyoto University, 3.Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4.Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

Yasumasa Hashimoto1,2, Hiroshi Kuniishi3,4, Masahiro Fukaya5, Hiroyuki Sakagami5, Keiji Wada3, Shin'ichi Takeda1, Masayuki Sekiguchi3, Yoshitsugu Aoki1 (1.Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan, 2.Department of Neurology, Kansai medical university, Japan, 3.Department of Degenerative Neurological Diseases, National Institute of Neuroscience, NCNP, 4.Department of Neuropsychopharmacology, National Institute of Mental Health, NCNP, 5.Department of Anatomy, Kitasato University School of Medicine)